FR2285886B2 - - Google Patents

Info

Publication number
FR2285886B2
FR2285886B2 FR7432772A FR7432772A FR2285886B2 FR 2285886 B2 FR2285886 B2 FR 2285886B2 FR 7432772 A FR7432772 A FR 7432772A FR 7432772 A FR7432772 A FR 7432772A FR 2285886 B2 FR2285886 B2 FR 2285886B2
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7432772A
Other languages
French (fr)
Other versions
FR2285886A2 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre Europeen de Recherches Mauvernay CERM
Original Assignee
Centre Europeen de Recherches Mauvernay CERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Europeen de Recherches Mauvernay CERM filed Critical Centre Europeen de Recherches Mauvernay CERM
Priority to FR7432772A priority Critical patent/FR2285886A2/fr
Publication of FR2285886A2 publication Critical patent/FR2285886A2/fr
Application granted granted Critical
Publication of FR2285886B2 publication Critical patent/FR2285886B2/fr
Granted legal-status Critical Current

Links

FR7432772A 1974-09-27 1974-09-27 Procede de synthese de tetrahydro 1,4-oxazines 2,4-disubstituees Granted FR2285886A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7432772A FR2285886A2 (fr) 1974-09-27 1974-09-27 Procede de synthese de tetrahydro 1,4-oxazines 2,4-disubstituees

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7432772A FR2285886A2 (fr) 1974-09-27 1974-09-27 Procede de synthese de tetrahydro 1,4-oxazines 2,4-disubstituees

Publications (2)

Publication Number Publication Date
FR2285886A2 FR2285886A2 (fr) 1976-04-23
FR2285886B2 true FR2285886B2 (Direct) 1979-03-30

Family

ID=9143538

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7432772A Granted FR2285886A2 (fr) 1974-09-27 1974-09-27 Procede de synthese de tetrahydro 1,4-oxazines 2,4-disubstituees

Country Status (1)

Country Link
FR (1) FR2285886A2 (Direct)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2553411B1 (fr) * 1983-10-14 1986-08-01 Lafon Labor Derives de 2-halogenophenyl-morpholine, procede de preparation et utilisation en therapeutique
GB8929331D0 (en) * 1989-12-29 1990-02-28 Shell Int Research Piperidine derivatives
TW200740779A (en) 2005-07-22 2007-11-01 Mitsubishi Pharma Corp Intermediate compound for synthesizing pharmaceutical agent and production method thereof
JP2013526583A (ja) 2010-05-21 2013-06-24 リサーチ・トライアングル・インスティチュート フェニルモルホリンおよびその類似体
ES2546492T3 (es) 2010-05-21 2015-09-24 Research Triangle Institute Derivados de 1-fenilmorfolina como análogos de hidroxibupropion para tratar drogodependencia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1564792A (Direct) * 1968-03-04 1969-04-25

Also Published As

Publication number Publication date
FR2285886A2 (fr) 1976-04-23

Similar Documents

Publication Publication Date Title
DK140350C (Direct)
FR2285887B1 (Direct)
DK152975A (Direct)
DK136248C (Direct)
DK136257C (Direct)
DK121074A (Direct)
CS170700B1 (Direct)
CS175801B1 (Direct)
CS172642B1 (Direct)
CS171041B1 (Direct)
CS170982B1 (Direct)
DE2423712A1 (Direct)
DE2439182A1 (Direct)
CH590594A5 (Direct)
DD114485A1 (Direct)
CH594180A5 (Direct)
CH595169A5 (Direct)
CH602200A5 (Direct)
CH603688A5 (Direct)
CH607176A5 (Direct)
CH614156A5 (Direct)
CH592539A5 (Direct)
CH588902A5 (Direct)
CH585928B5 (Direct)
CH585354A5 (Direct)

Legal Events

Date Code Title Description
CD Change of name or company name